Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects-Reference-Cited by-同舟云学术

Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects

Published:2009-06 Issue:6 Volume:31 Page:1256-1263
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Deng Sheng,Chen Xiao-Ping,Cao Dan,Yin Tao,Dai Zhi-Yong,Luo Jian,Tang Ling,Li Yuan-Jian

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. In vitro cytochrome P450 inhibition and induction;Walsky;Curr Drug Metab.,2008

2. Transporter-mediated drug interactions: Clinical implications and in vitro assessment;Lin;Expert Opin Drug Metab Toxicol.,2007

3. New strategies to address drug-drug interactions involving OATPs;Poirier;Curr Opin Drug Discov Devel.,2007

4. Biotransformation of pravastatin sodium in humans;Everett;Drug Metab Dispos.,1991

5. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions;Shitara;Pharmacol Ther.,2006

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Account of Distinct Change in Organic Anion Transporting Polypeptide 1B (OATP1B) Substrate Pharmacokinetics during OATP1B-Mediated Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling;Drug Metabolism and Disposition;2024-05-13

2. Rifampin- and Silymarin-Mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse Model;Molecular Pharmaceutics;2024-03-26

3. Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers;Frontiers in Pharmacology;2023-04-06

4. Quantitative prediction of OATP1B-mediated drug–drug interactions using endogenous biomarker coproporphyrin I;Xenobiotica;2022-04-03

5. Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interaction Potential of Vemurafenib Using R-Value and Physiologically-Based Pharmacokinetic Models;Journal of Pharmaceutical Sciences;2021-01